Trends Pharmacol Sci

• 

  Publication Venue For

  • Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery..  42:283-299. 2021
  • A Thermal Exhaust Port on the Death Star of Plasmodium falciparum-Infected Erythrocytes..  41:508-511. 2020
  • Dawn of a New RAMPage..  41:249-265. 2020
  • Updating Neuroimmune Targets in Central Nervous System Dysfunction..  40:482-494. 2019
  • Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale..  37:933-944. 2016
  • Tristetraprolin as a Therapeutic Target in Inflammatory Disease..  37:811-821. 2016
  • Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury..  36:605-616. 2015
  • What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling..  35:639-647. 2014
  • Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development..  33:449-455. 2012
  • The Valley of Death in anticancer drug development: a reassessment..  33:173-180. 2012
  • An interview with Robert J. Lefkowitz..  33:51-52. 2012
  • Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer..  32:644-651. 2011
  • β-Arrestin-mediated receptor trafficking and signal transduction..  32:521-533. 2011
  • Matrix metalloprotease regulation of neuropathic pain..  30:336-340. 2009
  • The true nature of pharmacogenomic associations?.  21:461. 2000
  • Reply: receptor specificity of G-protein-coupled receptor kinases..  21:366-367. 2000